drugset / Trial / NCT07535723

Botulinum Toxin and/or Greater Occipital Nerve Block for Patients With Chronic Migraine

NCT07535723

Not yet recruiting 90 enrolled Beni-Suef University Cairo University · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

Chronic migraine is a debilitating neurological disorder that significantly affects patients' daily functioning, mental health, and quality of life. Management typically includes acute and preventive treatments, but effectiveness can be limited due to medication overuse or delayed onset of action. OnabotulinumtoxinA injections provide proven long-term preventive benefits, while Greater Occipital Nerve (GON) block offers rapid but short-term relief. Although both treatments are used individually, evidence on the combined effect is limited. This randomized controlled trial aims to evaluate the efficacy and safety of combining OnabotulinumtoxinA injections with GON block, assessing improvements in headache frequency, severity, and patient quality of life compared to single therapy.

Timeline

Start
2026-04
Primary completion
2026-10
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 155 iu Intramuscular

Indications